Protein Therapeutics Market Worth $ 290, 691.88 Million By 2027, at 6.86% CAGR – Report by Market Research Future (MRFR)

Protein Therapeutics Market Insights and Industry Analysis by Type (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon), Application (Cancer, Metabolic Disorders, Immunologic Disorders, Hematological Disorders), Protein Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines), End User (Hospitals and Clinics, Specialty Centers,), Competitive Market Size, Share, Trends, and Forecast to 2027


New York, US, June 15, 2021 (GLOBE NEWSWIRE) -- Protein Therapeutics Market Overview:

According to a comprehensive research report by Market Research Future (MRFR), “Protein Therapeutics Market - Information by Type, Application, Protein Function, End User and Region - Forecast till 2027” the market is estimated to reach USD 290,691.88 Million by 2027 at a 6.86% CAGR.

Market Scope:

Therapeutic protein drugs are one of the significant classes of medicines as these drugs are expended in the handling and managing of diverse diseases, such as infectious diseases and cancer. The intensifying frequency of chronic disorders such as diabetes is anticipated to impact the protein therapeutics market growth throughout the forecast period. The swift technological developments in the field of protein therapeutics are anticipated to affect their demand encouragingly.

Market Drivers and Dynamic Growth Indicators

  • The surging use of monoclonal antibodies (MABs) in the treatment of several diseases is predicted to spur the protein therapeutic market. The escalating awareness of protein therapeutics is also anticipated to push the evolution of the global market throughout the forecast period.
  • The growing approval of plasma-derived therapies for the managing of chronic disorders is likely to boost the protein therapeutics market in the near future. The growing government schemes for the advance of the healthcare sector are anticipated to deliver promising opportunities for the protein therapeutics market.

Market Restraints:

  • The high cost of protein therapies is likely to restrain the market development.

Get Free Sample PDF Brochure @

Key Players:

The distinguished companies in the protein therapeutics market are:

  • Amgen Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Baxter International Inc. (US)
  • Sanofi (France)
  • Eli Lilly and Company (US)
  • Johnson & Johnson (US)
  • Merck & Co., Inc. (US)
  • Novo Nordisk A/S (Denmark)
  • Abbott Laboratories (US)
  • CSL Behring (US)
  • Bristol Myers Squibb Co. (US)
  • Pfizer Inc. (US)
  • Biogen, Inc. (US)

The research in the market is estimated to create ample opportunities for development in the upcoming period. Genentech and Roche have joined with The Weill Neurohub to hasten the expansion of new therapeutics targeting brain diseases and illnesses of the central nervous system (CNS). Roche and Genentech will join powers with The Weill Neurohub as a division of the Alliance for Therapies in Neuroscience (ATN) for ten years to cooperate on and improve neuroscience research. As a component of the ATN, Genentech will deliver UCSF and UC Berkeley up to USD 53m throughout the ten-year research cycle. The early areas of concentration for the ATN are CRISPR-based therapeutics, neurodegeneration, protein degradation, functional genomics in human brain cells, and sleep machines and circuits.

BigHat Biosciences, an innovative protein therapeutics corporation and designer of an AI-guided antibody design platform, announced it has solicited USD 19 million in an oversubscribed Series A funding cycle. The fresh capital will be exploited to enlarge the BigHat scientific and technical units. The company is currently hiring exceptional AI/ML engineers, antibody and protein engineers, and computational biologists. Moreover, the backing will support additional platform expansion, scaling volume, and development of BigHat’s inner therapeutic programs for human clinical trials.

Browse In-depth Market Research Report (108 Pages) on Protein Therapeutics:

Market Segmentation:

Global Protein Therapeutics Market is segmented as follows:

  • By Type: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon.
  • By Application: Cancer, Metabolic Disorders, Immunologic Disorders, Hematological Disorders.
  • By Protein Function: Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines.
  • By End User: Hospitals and Clinics, Specialty Centers.

The use of therapeutic proteins for manufacturing vaccines as they provide defense against autoimmune diseases, foreign agents, and cancer is likely to promote the market. hospitals and clinics are also estimated to add to the growing need for protein therapeutics products which is expected to drive the growth of this segment

Share your Queries @

Regional Analysis:

America's protein therapeutics market is the principal regional market. The collective government initiatives and the intensifying concerns in terms of safety and health of healthcare professionals are furthering the demand for protein therapeutics. Furthermore, the intensifying occurrence of cancer is one of the key factors accountable for the evolution of the protein therapeutics market in the forecast period. The healthcare market in the European regional markets consists of France, Germany, the UK, and Italy and is anticipated to display a surge in healthcare spending, growing cases of multiple sclerosis, rheumatoid arthritis, and chronic inflammatory demyelinating polyneuropathy thus developing the protein therapeutics market throughout the forecast period. The Asia Pacific protein therapeutics market is the quickest growing regional market. Developing market companies in the unexploited region, snowballing R&D in the protein therapeutics sector, mounting emphasis of government toward vaccination to stop various diseases, and an enormous target population are a few of the influences influencing the protein therapeutics market growth.

Discover more Research Reports on Healthcare Industry by Market Research Future:

Generic Injectables Market Research Report, by Product Type (Monoclonal antibodies, Cytokines, Insulin, Vaccines), Container (Vials, Ampoules, Premix, Prefilled syringes), Application (Oncology, Anaesthesia, Anti-infectives, Cardiovascular), Distribution Channel (Hospital pharmacy, Retail pharmacy, Drug stores, Online stores) – Global Forecast Till 2027

Oxygen Therapy Equipment Market: By Product (Oxygen Source Equipment, Oxygen Delivery Devices), Portability (Stationary Oxygen Therapy Devices, Portable Oxygen Therapy Devices), Application (Cystic Fibrosis, Pneumonia) — Global Forecast till 2027

Mobile Radiography Systems Market Research Report, by Type (In-Line, Battery-Powered), Imaging (Film, Computed Radiography, Direct Digital), Application (Orthopedic Imaging, Chest Imaging, Dental Imaging), End User, and Region — Global Forecast till 2027

Healthcare RFID Market: Information By Component (Tags, Readers, Middleware, Printers), Application (Equipment Tracking, Medicine Tracking, Others), End-User (Pharmaceutical and Biotechnology Companies, Hospitals, Others) — Global Forecast till 2027

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter


Contact Data